Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEAFAR Study: Faricimab in South Asian Patients With Diabetic Macular Oedema
NCT07753616Phase 4Not yet recruiting
- Sponsor
- Birmingham and Midland Eye Centre
- Start
- Nov 2026
- Primary completion
- Nov 2029
01
Overview
A Phase 4 trial of faricimab in diabetic macular edema (DME), sponsored by Birmingham and Midland Eye Centre. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
faricimab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07753616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07753616.